DrugDashboards

Ondansetron

Ondansetron · ONDANSETRON HYDROCHLORIDE 2 mg/mL · Injection · Intramuscular; Intravenous · Fosun Pharma USA Inc.

NDC 72266-0124-01 · 1 VIAL in 1 CARTON / 20 mL in 1 VIAL · ANDA · View full market →

The short version

16 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.1700 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1700per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.0880per billing unit (1 MG)HCPCS J2405 · Jul 1, 2026
  • Part D plans paid (avg)$0.5002per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Sep 2020Sep 2026$0.17
26 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$5.00
Reported to Texas DSHS · 2026 annual filing · Fosun Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.088
HCPCS J2405 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$126,953
34,569 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for ondansetron (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $14.79 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA090648
TE code
AP
Approval date
Jun 15, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ondansetron (Injection)

LabelerStrengthFirst seenLast seen
Fosun Pharma USA Inc.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
West-Ward Pharmaceuticals CorpONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.ONDANSETRON 2 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Jvet Pharmaceuticals LlcONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Hikma Pharmaceuticals USA Inc.ONDANSETRON HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ondansetron — NDC 72266-0124-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72266012401.

Free to cite with attribution — see how the data is put together.